Segment Information (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended September 30,				Nine months ended September 30,
Sale of Product	2020		2019		2020		2019
Radiochemical Products	$	1,294,546	$	936,656	$	3,162,820	$	2,173,995
Cobalt Products		544,989		97,849		1,075,275		687,177
Nuclear Medicine Standards		958,293		1,022,291		2,778,290		3,053,909
Radiological Services		54,760		280,692		171,048		1,086,098
Fluorine Products		11,700		—		172,200		—
Total Segments		2,864,288		2,337,488		7,359,633		7,001,179
Corporate revenue		—		—		—		—
Total Consolidated	$	2,864,288	$	2,337,488	$	7,359,633	$	7,001,179

	Three months ended September 30,				Nine months ended September 30,
Depreciation and Amortization	2020		2019		2020		2019
Radiochemical Products	$	10,089	$	9,892	$	30,797	$	27,978
Cobalt Products		8,761		1,269		26,284		3,371
Nuclear Medicine Standards		15,842		15,954		47,820		47,246
Radiological Services		8,285		8,636		25,440		25,908
Fluorine Products		28,512		28,465		85,505		85,367
Total Segments		71,489		64,216		215,846		189,870
Corporate depreciation and amortization		3,491		2,394		10,103		7,184
Total Consolidated	$	74,980	$	66,610	$	225,949	$	197,054

	Three months ended September 30,						Nine months ended September 30,
Segment Income (Loss)	2020			2019			2020			2019
Radiochemical Products	$	542,814		$	331,988		$	929,162		$	680,990
Cobalt Products		342,724			38,517			542,394			353,639
Nuclear Medicine Standards		181,097			180,828			483,454			509,571
Radiological Services		34,145			482,414			5,684			(107,541	)
Fluorine Products		(26,640	)		(36,026	)		59,770			(113,448	)
Total Segments		1,074,140			997,721			2,020,464			1,323,211
Corporate loss		(767,090	)		(761,259	)		(1,906,580	)		(2,295,900	)
Net Income (Loss)	$	307,050		$	236,462		$	113,884		$	(972,689	)

	Three months ended September 30,				Nine months ended September 30,
Expenditures for Segment Assets	2020		2019		2020		2019
Radiochemical Products	$	—	$	3,994	$	—	$	18,839
Cobalt Products		—		47,338		—		50,831
Nuclear Medicine Standards		—		1,750		—		6,700
Radiological Services		—		—		—		—
Fluorine Products		—		—		1,565		1,589
Total Segments		—		53,082		1,565		77,959
Corporate purchases		5,179		—		5,179		—
Total Consolidated	$	5,179	$	53,082	$	6,744	$	77,959

	September 30,		December 31,
Segment Assets	2020		2019
Radiochemical Products	$	748,527	$	511,381
Cobalt Products		1,175,804		3,369,828
Nuclear Medicine Standards		2,058,071		2,111,225
Radiological Services		90,263		106,374
Fluorine Products		5,393,868		5,477,808
Total Segments		9,466,533		11,576,616
Corporate assets		5,495,325		3,680,179
Total Consolidated	$	14,961,858	$	15,256,795